Biblio Discovery — Demo Discovery Service

3 results for "Peng-Chan Lin"

Showing 1–3 · 0.22 seconds · RSS

  1. Journal Article Full text

    Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

    Jason C. Hsu; Jia-Yu Lin; May-Ying Hsu et al.

    PLOS ONE, Vol. 13 No. 8 · 2018 · English · PLOS Scopus

    Background: Since 2012, several immune checkpoint inhibitors have been approved by the Taiwan FDA for various types of cancer treatment. However, none of them are covered by Taiwan National Health Insurance due to the fact that they are expensive, and there is a lack of clinical evidence as to…

  2. Journal Article Full text

    Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment

    Jason C. Hsu; Jia-Yu Lin; Peng-Chan Lin et al.

    PLOS ONE, Vol. 14 No. 12 · 2019 · English · PLOS Scopus

    Objective: This study is aimed toward establishing a decision-making model with multiple criteria for appraisal and reimbursement to compare the attitudes of different stakeholders toward various dimensions and criteria and to evaluate the five targeted therapies (bevacizumab, cetuximab…

  3. Journal Article Full text

    Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses

    Peng-Chan Lin; Yi-Fang Yang; Yu-Chang Tyan et al.

    PLOS ONE, Vol. 11 No. 7 · 2016 · English · PLOS Scopus

    Colorectal cancer is the most common form of cancer in the world, and the five-year survival rate is estimated to be almost 90% in the early stages. Therefore, the identification of potential biomarkers to assess the prognosis of early stage colorectal cancer patients is critical for further…